First Republic Investment Management, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $20,707 - $44,718	12,704 New	12,704 $21,000
Q2 2022 Aug 16, 2022	BUY	$2.2 - $4.2 $511,821 - $977,113	232,646 Added 415.7%	288,611 $687,000
Q1 2022 May 16, 2022	BUY	$2.83 - $8.69 $5,660 - $17,380	2,000 Added 3.71%	55,965 $226,000
Q3 2021 Nov 12, 2021	BUY	$9.15 - $13.28 $493,779 - $716,655	53,965 New	53,965 $625,000

Others Institutions Holding DNA

# of Institutions

Shares Held

48.1M

Call Options Held

Put Options Held

Black Rock Inc. New York, NY

42M
Shares

$394 Million
0.0% of portfolio
Titleist Asset Management, Ltd. San Antonio, TX

2.31M
Shares

$21.6 Million
0.92% of portfolio
Putnam Investments LLC Boston, MA

1.5M
Shares

$14.1 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.15M
Shares

$10.7 Million
0.0% of portfolio
Benjamin F. Edwards & Company, Inc. St. Louis, MO

235K
Shares

$2.2 Million
0.0% of portfolio

View Full List

About Ginkgo Bioworks Holdings, Inc.

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

More about DNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account